Cesca Therapeutics Profit Margin 2006-2018 | KOOL
Current and historical gross margin, operating margin and net profit margin for Cesca Therapeutics (KOOL) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Cesca Therapeutics net profit margin as of September 30, 2018 is -323.73%.
|Cesca Therapeutics Annual Profit Margins
|Cesca Therapeutics Quarterly Profit Margins
||Medical Instruments Manufacturing
Cesca Therapeutics Inc. is engaged in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It also develops and manufactures automated blood and bone marrow processing systems and companion disposable products that enable the separation, processing and preservation of cell and tissue therapy products. The Company sells its products in approximately 30 countries throughout the world to customers that include private and public cord blood banks, surgeons, hospitals and research institutions. Cesca Therapeutics Inc., formerly known as ThermoGenesis Corp., is headquartered in Rancho Cordova, California.